ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Barrier Biotech Limited

Barrier Biotech Limited is an active company incorporated on 18 April 1990 with the registered office located in Attleborough, Norfolk. Barrier Biotech Limited was registered 35 years ago.
Status
Active
Active since incorporation
Company No
02493312
Private limited company
Age
35 years
Incorporated 18 April 1990
Size
Micro
Turnover is under £1M
Balance sheet is under £500,000
Under 10 employees
Confirmation
Submitted
Dated 22 December 2025 (1 month ago)
Next confirmation dated 22 December 2026
Due by 5 January 2027 (11 months remaining)
Last change occurred 8 years ago
Accounts
Submitted
For period 1 Nov31 Oct 2024 (1 year)
Accounts type is Total Exemption Full
Next accounts for period 31 October 2025
Due by 31 July 2026 (6 months remaining)
Contact
Address
36 Haverscroft Industrial Estate
New Road
Attleborough
Norfolk
NR17 1YE
Same address for the past 29 years
Telephone
01953456363
Email
Available in Endole App
People
Officers
5
Shareholders
1
Controllers (PSC)
1
Director • Secretary • British • Lives in England • Born in Dec 1988
Director • British • Lives in England • Born in Jan 1984
Director • British • Lives in England • Born in Nov 1984
Director • British • Lives in England • Born in Jan 1949
Barrier Holdings Limited
PSC
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Barrier Holdings Limited
Katherine Winnaretta Back, Nigel Barry Quarles Back, and 1 more are mutual people.
Active
Quarles Limited
Nigel Barry Quarles Back is a mutual person.
Active
Washingford Research Limited
Nigel Barry Quarles Back is a mutual person.
Active
Norwich School
Nigel Barry Quarles Back is a mutual person.
Active
Financials
Net Assets, Total Assets & Total Liabilities (2015–2024)
Period Ended
31 Oct 2024
For period 31 Oct31 Oct 2024
Traded for 12 months
Cash in Bank
£506.1K
Decreased by £53.36K (-10%)
Turnover
Unreported
Same as previous period
Employees
6
Same as previous period
Total Assets
£690.42K
Decreased by £73.03K (-10%)
Total Liabilities
-£425.77K
Increased by £302.83K (+246%)
Net Assets
£264.65K
Decreased by £375.86K (-59%)
Debt Ratio (%)
62%
Increased by 45.56% (+283%)
Latest Activity
Confirmation Submitted
1 Month Ago on 23 Dec 2025
Mr Phil Guy O'farrell Appointed
2 Months Ago on 31 Oct 2025
Cecilia Paris Back Resigned
2 Months Ago on 31 Oct 2025
Katherine Winnaretta Back Appointed
2 Months Ago on 31 Oct 2025
Mrs Emma Adelaide O'farrell Appointed
2 Months Ago on 31 Oct 2025
Katherine Winnaretta Back Appointed
2 Months Ago on 31 Oct 2025
Philippa Lucy Foster Back Resigned
2 Months Ago on 31 Oct 2025
Confirmation Submitted
10 Months Ago on 17 Mar 2025
Full Accounts Submitted
11 Months Ago on 13 Feb 2025
Confirmation Submitted
1 Year 10 Months Ago on 23 Mar 2024
Get Credit Report
Discover Barrier Biotech Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Confirmation statement made on 22 December 2025 with no updates
Submitted on 23 Dec 2025
Appointment of Mr Phil Guy O'farrell as a director on 31 October 2025
Submitted on 28 Nov 2025
Termination of appointment of Philippa Lucy Foster Back as a director on 31 October 2025
Submitted on 27 Nov 2025
Appointment of Katherine Winnaretta Back as a director on 31 October 2025
Submitted on 27 Nov 2025
Appointment of Mrs Emma Adelaide O'farrell as a director on 31 October 2025
Submitted on 27 Nov 2025
Appointment of Katherine Winnaretta Back as a secretary on 31 October 2025
Submitted on 27 Nov 2025
Termination of appointment of Cecilia Paris Back as a secretary on 31 October 2025
Submitted on 27 Nov 2025
Confirmation statement made on 12 March 2025 with no updates
Submitted on 17 Mar 2025
Total exemption full accounts made up to 31 October 2024
Submitted on 13 Feb 2025
Confirmation statement made on 12 March 2024 with no updates
Submitted on 23 Mar 2024
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year